Trials / Unknown
UnknownNCT04851054
Postoperative VEGF and Recurrence After Colon Cancer Surgery
Postoperative Serum VEGF Concentration as an Independent Prognostic Factor for Recurrence After Curative Colon Cancer Surgery. Multicentric Study.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 280 (estimated)
- Sponsor
- Hospital del Mar · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to study the relationship between the angiogenic response to surgical aggression, determined through the serum levels of vascular endothelial growth factor (VEGF) on postoperative day four, and the tumor recurrence in patients with colon cancer operated with a curative intention.
Detailed description
DESIGN: Prospective multicentric study. PARTICIPATION: Colorectal Surgery Units of Hospital del Mar, Barcelona; Hospital Universitari Joan XXIII, Tarragona; Hospital Universitari La Fe, Valencia; Hospital Clínico San Carlos, Madrid; Hospital General de Granollers, Granollers; Hospital Germans Trias i Pujol, Badalona; Athalaia, Xarxa Assistencial Universitària de Manresa, Manresa STUDY SUBJECTS: 280 consecutive patients with non-metastatic colon cancer in whom a curative intent resection is performed. DETERMINATIONS: Determination of the proangiogenic cytokine VEGF in serum on the postoperative day four to assess its relationship with oncological results on long-term follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgery for colon cancer with intention to cure | Surgery by open or laparoscopic approach |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-03-30
- Completion
- 2021-12-31
- First posted
- 2021-04-20
- Last updated
- 2021-04-20
Source: ClinicalTrials.gov record NCT04851054. Inclusion in this directory is not an endorsement.